BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ianiro G, Mullish BH, Kelly CR, Sokol H, Kassam Z, Ng S, Fischer M, Allegretti JR, Masucci L, Zhang F, Keller J, Sanguinetti M, Costello SP, Tilg H, Gasbarrini A, Cammarota G. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020;5:430-432. [PMID: 32192627 DOI: 10.1016/s2468-1253(20)30082-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 33.5] [Reference Citation Analysis]
Number Citing Articles
1 Kazemian N, Kao D, Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int J Mol Sci 2021;22:3004. [PMID: 33809421 DOI: 10.3390/ijms22063004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. J Clin Med 2020;9:E1757. [PMID: 32517023 DOI: 10.3390/jcm9061757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
3 Mustafa MI, Abdelmoneim AH, Mahmoud EM, Makhawi AM. Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors. Mediators Inflamm. 2020;2020:8198963. [PMID: 33029105 DOI: 10.1155/2020/8198963] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
4 He J, He X, Ma Y, Yang L, Fang H, Shang S, Xia H, Lian G, Tang H, Wang Q, Wang J, Lin Z, Wen J, Liu Y, Zhai C, Wang W, Jiang X, Xuan J, Liu M, Lu S, Li X, Wang H, Ouyang C, Cao M, Lin A, Zhang B, Wu D, Chen Y, Xiao C. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China. Microb Cell Fact 2021;20:216. [PMID: 34838016 DOI: 10.1186/s12934-021-01705-0] [Reference Citation Analysis]
5 Yau YK, Mak WYJ, Lui NSR, Ng WYR, Cheung CYK, Li YLA, Ching YLJ, Chin ML, Lau HSL, Chan KLF, Chan KSP, Ng SC. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021;9:1027-38. [PMID: 34623758 DOI: 10.1002/ueg2.12160] [Reference Citation Analysis]
6 Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
7 Mirjalali H, Nazemalhosseini-Mojarad E, Yadegar A, Mohebbi SR, Baghaei K, Shahrokh S, Asadzadeh Aghdaei H, Zali MR. The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2. Front Public Health 2020;8:553589. [PMID: 33194955 DOI: 10.3389/fpubh.2020.553589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Alimohammadi M, Naderi M. Effectiveness of Ozone Gas on Airborne Virus Inactivation in Enclosed Spaces: A Review Study. Ozone: Science & Engineering 2021;43:21-31. [DOI: 10.1080/01919512.2020.1822149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Olesen SW, Zaman A, Osman M, Ramakrishna B. Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation. Open Forum Infect Dis 2020;7:ofaa499. [PMID: 33235890 DOI: 10.1093/ofid/ofaa499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Mishima Y, Ishihara S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci. 2020;21. [PMID: 33212919 DOI: 10.3390/ijms21228664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
11 Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res 2020;226:57-69. [PMID: 32827705 DOI: 10.1016/j.trsl.2020.08.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 33.5] [Reference Citation Analysis]
12 Sessa A, Mazzola A, Lim C, Atif M, Pappatella J, Pourcher V, Scatton O, Conti F. COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report. World J Gastroenterol 2020; 26(44): 7076-7084 [PMID: 33311951 DOI: 10.3748/wjg.v26.i44.7076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Rubin DT, Abreu MT, Rai V, Siegel CA;  International Organization for the Study of Inflammatory Bowel Disease. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020;159:6-13.e6. [PMID: 32272113 DOI: 10.1053/j.gastro.2020.04.002] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 45.5] [Reference Citation Analysis]
14 Kelly CR, Laine LA, Wu GD. Monitoring Fecal Microbiota Transplantation Practice in a Rapidly Evolving Health and Regulatory Environment. Gastroenterology 2020;159:2004-6. [PMID: 32841646 DOI: 10.1053/j.gastro.2020.08.039] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Malfertheiner P, Bornschein J, Ricciardiello L. COVID-19: Don't Neglect the Gastrointestinal Tract! Dig Dis. 2020;38:259-260. [PMID: 32349002 DOI: 10.1159/000508289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Aguiar-Oliveira ML, Campos A, R Matos A, Rigotto C, Sotero-Martins A, Teixeira PFP, Siqueira MM. Wastewater-Based Epidemiology (WBE) and Viral Detection in Polluted Surface Water: A Valuable Tool for COVID-19 Surveillance-A Brief Review. Int J Environ Res Public Health 2020;17:E9251. [PMID: 33321987 DOI: 10.3390/ijerph17249251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
18 Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol 2020; 26(19): 2323-2332 [PMID: 32476796 DOI: 10.3748/wjg.v26.i19.2323] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 47] [Article Influence: 30.0] [Reference Citation Analysis]
19 D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol. 2020;18:1663-1672. [PMID: 32278065 DOI: 10.1016/j.cgh.2020.04.001] [Cited by in Crossref: 210] [Cited by in F6Publishing: 182] [Article Influence: 105.0] [Reference Citation Analysis]
20 Daughton CG. Wastewater surveillance for population-wide Covid-19: The present and future. Sci Total Environ 2020;736:139631. [PMID: 32474280 DOI: 10.1016/j.scitotenv.2020.139631] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 48.0] [Reference Citation Analysis]
21 Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020;33. [PMID: 32580969 DOI: 10.1128/cmr.00028-20] [Cited by in Crossref: 222] [Cited by in F6Publishing: 125] [Article Influence: 111.0] [Reference Citation Analysis]
22 Rampelli S, Biagi E, Turroni S, Candela M. Retrospective Search for SARS-CoV-2 in Human Faecal Metagenomes. SSRN Journal. [DOI: 10.2139/ssrn.3557962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Mohapatra RK, Dhama K, Mishra S, Sarangi AK, Kandi V, Tiwari R, Pintilie L. The microbiota-related coinfections in COVID-19 patients: a real challenge. Beni Suef Univ J Basic Appl Sci 2021;10:47. [PMID: 34458380 DOI: 10.1186/s43088-021-00134-7] [Reference Citation Analysis]
24 Concas G, Barone M, Francavilla R, Cristofori F, Dargenio VN, Giorgio R, Dargenio C, Fanos V, Marcialis MA. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig Dis Sci 2021. [PMID: 34333726 DOI: 10.1007/s10620-021-07158-0] [Reference Citation Analysis]
25 Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
26 Mehta SR, Yen EF. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Transl Res 2021;230:197-207. [PMID: 33278650 DOI: 10.1016/j.trsl.2020.11.013] [Reference Citation Analysis]
27 Liu Y, Tran DQ, Lindsey JW, Rhoads JM. The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases. Adv Exp Med Biol 2021;1278:191-203. [PMID: 33523449 DOI: 10.1007/978-981-15-6407-9_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Barengolts E, Smith ED. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review. Endocr Pract 2020;26:1186-95. [PMID: 33471720 DOI: 10.4158/EP-2020-0336] [Reference Citation Analysis]
29 Wu B, Huang M, Jiao G, Hu C, Yang Y, Jingyu C; China Lung Transplantation Alliance., National Lung Transplantation Expert Group for COVID-19. Lung transplantation during the outbreak of Coronavirus Disease 2019 in China. J Thorac Cardiovasc Surg 2020:S0022-5223(20)33147-0. [PMID: 33461803 DOI: 10.1016/j.jtcvs.2020.10.154] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Garland V, Kumar AB, Borum ML. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations. J Natl Med Assoc. 2021;113:142-146. [PMID: 32807512 DOI: 10.1016/j.jnma.2020.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ianiro G, Bibbò S, Masucci L, Quaranta G, Porcari S, Settanni CR, Lopetuso LR, Fantoni M, Sanguinetti M, Gasbarrini A, Cammarota G. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis 2020;52:1390-5. [PMID: 33004295 DOI: 10.1016/j.dld.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Haifer C, Leong RW, Paramsothy S. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Curr Opin Pharmacol 2020;55:8-16. [PMID: 33035780 DOI: 10.1016/j.coph.2020.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
34 Zhang J, Garrett S, Sun J. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis 2021;8:385-400. [PMID: 33521210 DOI: 10.1016/j.gendis.2020.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
35 Di Pilato V, Morecchiato F, Rizzato C, Quaranta G, Fais R, Gandolfo C, Antonelli A, Cusi MG, Pistello M, Rossolini GM, Sanguinetti M, Lupetti A, Masucci L. Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation. Microorganisms 2022;10:284. [DOI: 10.3390/microorganisms10020284] [Reference Citation Analysis]
36 Verma S, Manjunath SM, Ettishree, Singh A, Srivastava M, Sahoo KK, Vinuta S, Singh U. Coronavirus: An emergency for healthcare professionals. J Family Med Prim Care 2020;9:1815-9. [PMID: 32670924 DOI: 10.4103/jfmpc.jfmpc_462_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Ianiro G, Bibbò S, Porcari S, Settanni CR, Giambò F, Curta AR, Quaranta G, Scaldaferri F, Masucci L, Sanguinetti M, Gasbarrini A, Cammarota G. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut Microbes 2021;13:1994834. [PMID: 34709989 DOI: 10.1080/19490976.2021.1994834] [Reference Citation Analysis]
38 Ianiro G, Mullish BH, Kelly CR, Kassam Z, Kuijper EJ, Ng SC, Iqbal TH, Allegretti JR, Bibbò S, Sokol H, Zhang F, Fischer M, Costello SP, Keller JJ, Masucci L, van Prehn J, Quaranta G, Quraishi MN, Segal J, Kao D, Satokari R, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 2020;69:1555-63. [PMID: 32620549 DOI: 10.1136/gutjnl-2020-321829] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
39 Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. J Clin Exp Hepatol 2020;10:622-8. [PMID: 32837095 DOI: 10.1016/j.jceh.2020.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Arab J Gastroenterol. 2020;21:3-8. [PMID: 32253172 DOI: 10.1016/j.ajg.2020.03.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 29.0] [Reference Citation Analysis]
41 Green CA, Quraishi MN, Shabir S, Sharma N, Hansen R, Gaya DR, Hart AL, Loman NJ, Iqbal TH. Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward. Lancet Gastroenterol Hepatol. 2020;. [PMID: 32240618 DOI: 10.1016/s2468-1253(20)30089-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
42 Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.009] [Reference Citation Analysis]
43 Baryah ANS, Midha V, Mahajan R, Sood A. Impact of Corona Virus Disease-19 (COVID-19) pandemic on gastrointestinal disorders. Indian J Gastroenterol 2020;39:214-9. [PMID: 32749642 DOI: 10.1007/s12664-020-01071-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Vodnar DC, Mitrea L, Teleky BE, Szabo K, Călinoiu LF, Nemeş SA, Martău GA. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota. Front Cell Infect Microbiol 2020;10:575559. [PMID: 33363049 DOI: 10.3389/fcimb.2020.575559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
45 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]
46 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
47 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Roviello G, Iannone LF, Bersanelli M, Mini E, Catalano M. The gut microbiome and efficacy of cancer immunotherapy. Pharmacol Ther 2021;:107973. [PMID: 34453999 DOI: 10.1016/j.pharmthera.2021.107973] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Aguila EJT, Cua IHY, Dumagpi JEL, Francisco CPD, Raymundo NTV, Sy-Janairo MLL, Cabral-Prodigalidad PAI, Lontok MAD. COVID-19 and its effects on the digestive system and endoscopy practice. JGH Open. 2020;4:324-331. [PMID: 32514432 DOI: 10.1002/jgh3.12358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
50 Faraj J, Takanti V, Tavakoli HR. The Gut-Brain Axis: Literature Overview and Psychiatric Applications. Fed Pract 2021;38:356-62. [PMID: 34733087 DOI: 10.12788/fp.0159] [Reference Citation Analysis]
51 Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F, Brown Jr RS, Carr-Locke D, Cohen DE, Sharaiha RZ. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020; 26(14): 1546-1553 [PMID: 32327904 DOI: 10.3748/wjg.v26.i14.1546] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
52 Nandwana V, Debbarma S. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease. Cureus 2021;13:e16503. [PMID: 34430117 DOI: 10.7759/cureus.16503] [Reference Citation Analysis]
53 Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial. BMJ Open 2021;11:e048541. [PMID: 34168032 DOI: 10.1136/bmjopen-2020-048541] [Reference Citation Analysis]
54 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
55 Robba C, Battaglini D, Pelosi P, Rocco PRM. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med 2020;14:865-8. [PMID: 32567404 DOI: 10.1080/17476348.2020.1778470] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 35.5] [Reference Citation Analysis]
56 Chiu CH, Tsai MC, Cheng HT, Le PH, Kuo CJ, Chiu CT. Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic. J Formos Med Assoc 2021;120:791-3. [PMID: 32713786 DOI: 10.1016/j.jfma.2020.07.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Peyrin-Biroulet L. Will the Quality of Research Remain the Same During the COVID-19 Pandemic? Clin Gastroenterol Hepatol 2020;18:2142. [PMID: 32240830 DOI: 10.1016/j.cgh.2020.03.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
58 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Amjad W, Haider R, Malik A, Qureshi W. Insights into the management of anorectal disease in the coronavirus 2019 disease era. Therap Adv Gastroenterol 2021;14:17562848211028117. [PMID: 34290826 DOI: 10.1177/17562848211028117] [Reference Citation Analysis]
60 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Chen J, Zaman A, Ramakrishna B, Olesen SW. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank. Front Cell Infect Microbiol 2021;11:622949. [PMID: 33937092 DOI: 10.3389/fcimb.2021.622949] [Cited by in F6Publishing: 2] [Reference Citation Analysis]